Investigations showed that an iNOS-specific inhibitor reversed the impaired pressor responsiveness and endothelial function observed in rats with streptozotocin-induced diabetes, indicating that increased iNOS expression may play a role in diabetes-associated endothelial dysfunction [98]. This evidence concerns the gene NOS2 and diabetes mellitus.